You are on page 1of 9

CARDIOLOGY CENSUS D 3706, 3707,3608, 3503, 3504, , 2613, 2414, ICU5 CCU7

MARCH 4, 2018 T 3702 3604 2617


LUGTU/SEVILLA/BELISARIO/PALMEA
ANGHAD-RAMOS/SEVILLA/SO W 3507, 2615, 2502, 2519,2421,1517,1520,1523C,1419C,CCU1,O10
H 1509,1411, CCU3,P1

MEDICAL SUITE
ROOM AP NAME/AGE/ SEX NON CARDIAC DIA GNOSIS CARDIAC DIAGNOSIS DIAGNOSTIC RESULTS PRESENT PROBLEM/
# PROCEDURE/ FOLLOW UP/
MEDS
3804 HLC YU KI QUING 88M CAPMR HCVD 2V CAD SR NYHA FC IIIC WBC 7.7 PLT 291 HGB139 NA 126 K 3.9 CREA 44 2D ECHO
631164 HYPONATREMIA SEC TO POOR S/P PTCA 2016 ECG SR NSTTWC CAROTID DUPLEX
ORAL INTAKE 3/3 LOXEVA
DMT2 NAC ANGIOZEM REBAMIPIDE
METHYCOBALAMIN CLOPI
CILSOTAZOL GLIMEPERIDE
3806B ADC SAMUEL GAERLAN 59M UTI WBC 6.3 HGB 146 PLT 302 CIPRO
S/P COLO 3/3 INT EF 65% N LVD AND WT W/ AWMC, TSE NORMAL
HEMORRHOIDS
3702 TDY/ NLEE BERNARDO, JOSEPHINE HEMATOMA W/ ABSCESS HCVD, VALVULAR HEART 2/28 WBC 16.7 HGB 110 PLT 313 CREA 135 PT 16.38/1.49/49.4% Cbc ptpa crea 3/4
630773 53/F FORMATION PSOAS DISEASE, SEVERE MITRAL AV DUPLEX: RLE: 20-49% INSIGNFCANT STENOSIS R CFA DFA AND PROX TO MID REHAB
CKD 2 TO HTTNNS REGURGITATION 2 TO FLAIL SFA, <20% STENOSIS TGE REST OF ARTERIAL SEGMENT; LLE: <20% STENOSIS LEFT
T2DM POSTERIOR MITRAL VALVE DEIA, CFA AND SFA PROX TO DISTAL, NORMAL ABI REFERED TO NEURO
HTN LEAFLET CARDIAC VENOUS: NEGATIVE ACUTE DVT BOTH LE, DVVR L CVF AND DVF, SVVR L GSV
S/P CT GUIDED ASPIRATION DYSRRHYTMIA LONG STANDING
BIOPSY OF RIGHT PSOAS MASS AF MVR, NYHA IIB 2/27 HGB 113 WBC 17.9 PLT 293 PTPA 15.1/1.31/55.4% 2/27 CEFTAZIDIME
(5CC OF CLOTTING AND NON Tpi buR 60 ou-10 WBC 12.5 HGB 61 PLT 329 CREA 172 NA 133 K 3.9 ALB 38 HOLD WARFARIN
CLOTTING BLOOD) S/P MVR WITH ANNULOPLASTY PTOA 57.8/4.91/9% S/P 2 U PRBC AND 4U FFP
10/4 LINAGLIPTIN VERAPAMIL GLICLA
ECG NSR ATOR TELMISARTAN
WA CTSCAN: RIGHT PSOAS HEMATOMA, ASCITES, COLONIC
DIVERTICULIYTIS

EF61%
STUDY DONE IN ATRIAL FLUTTER
S/P MITRAL VALVE REPAIR
THICKENED MVL W/ MILD MR. THE ANNULUS IS HIGHLY
ECHOGENIC CONSISTENT W/ PRIOR MITRAL VALVE
REPAIR/ANNULOPLASTY RING. THERE IS MILD RESTRICTION
OF THE PMVL BUT AMVL HAS NORMAL MOBILITY W/ GOOD
COAPTATION DURING SYSTOLE
ST NORMAL TV W/ MILD TR
ST NORMAL PV W/ PR
NORMAL LVD W/ NORMAL CONTRACTILITY AND SYSTOLIC
FXN
SLIGHTLY DILATED LA
NORMAL RV DIMENSION W/ NORMAL CONTRACTILITY
NORMAL RA,MPA AND ARDS
INTACT INTERATRIAL SEPTUM AND INTERVENTRICULAR
SEPTUM
NO THROMBUS AND NO PE
MILD PULMO HTN W/ SPAP OF 49MMHG BY TR JET
3704 LTAN ENRIQUE LOZADA 75M MNTG WBC 7.12 HGB 140 PLT 280 MGH 3/5
631001 S/P TOTAL THYROIDECTOMT 3/1 ECG NSR
ECHO EF 71% N LVD W/ AWMC W/ DERA, MILD AS W/ MILD AR, N PAP
3706 DBY ANTONIO YU LIMBO CAPMR ASCVD 3V CAD S/P CABG ( 3/3 HGB 98 WBC 8.8 PLT 131 NA 136 K 4.5 CREA 301 CREA 3/5 URONE CS
627831 83/ M UTI CABG X 4 VESSELS LIMA TO 2/24 WBC 8.2 HGB 97 PLT 155 SEG 75 HD 3/5
AKI LAD, SVG TO LCX, SVG TO
S/P TIA JAN 2017, DMT2 RCA, SVG TO RAMUS)2006 NA 145 K 4.0 SGPT 10 CREA 226 S/P HD 3/3
S/P IJ CATHETER INSERTION, PAROXYSMAL AF IN 2/24 U/A PUS MORE THAN 100
RIGHT 1/27 MVR>SR> AF MVR SVR FREQ BLADDER UTZ: PORTATOMEGALY W/ RESIDUAL URINE 54% ECTRIN
S/P REMOVAL IJ CATH R 2/10 2/23 WBC 11.3 HGB 101 PC 170 CREA 257 O2 3LPM
PVCS , CHADSVASC 8
S/P L IJ CATH 2/13 2/19 HGB 120 WBC 32.8 PLT 202 CREA 371 UA PUS OVER 100 N3 DRIP 1 CC/HR
HASBLED6 HF NYHA IIIC
S/P FC INSERTION 2/24 2/16 DIDMER 1.10 DVT: NEGATIVE ENTRESTO- HOLD
S/P PCI LM TO PROX RAMUS 2/14 HGB 91 WBC 16.9 PLT 261 CREA 465 K 3.6
VIA FA 2/12 HGB 95 WBC 13.1 PLT 297 CREA 334 K 4 2/20 FLUCONAZOLE
6/9 ESBL URINE CS 2/8 MEROPENEM-COMPLETED
S/P CA-BGA RIGHT FEMORAL 2/5 HGB 96 WBC 7.7 S 58 PC 197 ICA 1.19 K4 2/4 HGB101 WBC 8.2 PLT 194 2/8 LEVOX-COMPELTED
ACCESS (SEVERE 3V CAD CREA 308 K 2.9
WITH SIG LM,PATENT LIMA- MEDS:DOXOPHYLLINE,
LAD, SVG TO RCA GRAFT, 1/21: BLOOD CS ESBL POSITIVE SENSITIVE TO MEROPENEM FLEXITIDE, SINECOD, PYROLVEX,
TOTALLY OCCLUDED SVG TO KLYTECALMOSERTIN, ALANERV,
RAMUS, WITH SVG TO LCX UA PC >100 SAMSCA BURINEX IMDUR
GRAFTS ECG AF MVR SPIRIVA ADEFLO NIACIN ASA
EF 44% CONCENTRIC LVH WITH MILD HYPOKINESIA OF ENTIRE IVS, METFORMIN TRAJENTA
ANTERIOR, INFERIOR AND LATERAL LVFWS FR MID TO APEX. THE REST OF LANOXIN URIFLOW
THE LV SEGMENTS ARE SEVERELY HYPOKINETIC W/ GRADE 2 DIASTOLIC CLOPI
DYSFUNCTION BIATRIAL DILATATION MITRAL SCLEROSIS WITH MODERATE NYSTATIN
ME AORTIC SCLEROSIS W/ AI 1+ MILD TR ATHEROSCLEROTIC AORTIC ROOT HOLD ASA
MILD PULMO HTN W/ PR COMPARED W/ 2D ECHO DONE 4/17/13 THERE
IS IMPROVEMENT OF WALL MOTION ABNORMALITY OF FEW SEGMENTS
W/ INCREASED EF FR 38 TO 44%. PULMONARY ARTERY PRESURE
DECREASED FR 61 TO 57MMHG.
3707 DBY HAN LIONG LAU 84/ M PLEURAL EFFUSION PROB SEC HCVD, BRADYARRHYTHMIA RBS 8.09 MMOL; PF SUGAR 6.54 MMOL/ L PMGH MONDAY
630251 TO CHF (IDIOVENTRICULAR RHYTHM) PD EVERY 4HRS
S/P TPI 8/10 2/26 PFA EXUDATIVE
S/P UTZ GUID THORA R 550C S/P PPI VVI 8/12/17 2/26 CHEST UTZ 693 CC R PLEURALFLUID IVF TC
2/26 S/P PD 2/28
CREA 300 K 4.3
S/P TENCHOFF INSERTION 2/28 HOLD CLOPI 3/3
2/10 HGB 103 WBC 6.3 PLT ADEQ CREA 243 K 4.73 NA 137
CEFOXITIN>3/1 COAMOX
CREA 289(243) NA 137 K4.13
CATAPRES CARVED SAMSCA
BURINEX KREMEZIN LANOXIN
ENTRESTO ALLOP FOLIC CLOPI
EPREX
3604 TDY ADELINA DY 53F ADRENAL MASS LEFT W/ HCVD PROB CAD 3/3 WBC 16.2 HGB 125 PLT 225 NA 130 K 2.9 KCL DRIP, KLYTE
631010 PROB HEPATIC METS AORTIC DISSECTION FR DVT: NEGATIVE FOR ACUTE DVT
DESCENDING THORACIC F/A NEGATIVE ERCEFLORA
AORTA TO R EXT ILIAC TRAMADOL DRIP
ARTERY WBC 16.8 PLT 263 SEG 68 NA 136 K 2.4 ALB 16 PT 164/1.45/51.3% PIPTAZO
S/P TEVA 2WKS AGO ECG NSR LAE NSTTWC MITOTANE
(CARDINAL) WA CTSCAN: NO HEMATOMA/ NO BLEEDING HOOLD LCONIDINE AND
ATENOLOL
TERAZOSIN LANOXIN
COLCHICINE ALLOPURINOL
3606 LTAN AMDEO BEN 61/ M CVA INFARCT POSTERIOR ASCVD PROB CAD 3/3 HGB 119 WBC 9.9 PLT 220 NA 136 K 4 CREA 64 AWAITING CRANIAL MRI
CIRCULATION 2017 2DECHO: EF 39% WITH HYPOKINESIA OF THE ENTIRE IVS, INF AND CIPRO METRO 3/2
MULTIPLE GASTRIC AND INFLATERAL FREE WALL NE DRIP CONSUMED
COLONIC ULCERS, T2DM WBC 6.8 HGB 125 PLT 255 SEG 49
PT 11.3 INR 1.01 98% ESCITALOPRAM 10MG 1/2 TAB
S/P EGD/PEG INSERTION 3/2 ACTIVITY APTT: 31.7 N 27.7 OD NEUROAID 3 TABS BID
CITICHOLINE 1 TAB BID
KELTICAN OD DUOBLOC35MG
OD MICARDIS 40MG ODHS
AMLODIPINE 5MG OD
TELMISARTAN ATOR
GALVUSMET BID
3609 LTAN RUFINO YU 82/ M T/C NERVE COMPRESSION ASCVD PROB CAD EF 49% N LVD AND WT WITH HYPOKINESIA OF THE INFERIOR AND PIASCLEDENE
LUMBAR AREA ANTERIOR IVS FROM MID TO BASE, AND INFERIOR AND ANTERIOR LVFW PREGABALIN BEETAB
OSTEOARTHRITIS FROM MID TO BASE DILATED LA AND RA N MPA DILATED AORTIC ROOT TH
MVLS W/O ROM WITH MILD MR: MAC TH RCC AND NCC WITHOUT ROM

1
WITH MILD AR; AAC N TV AND PV WITH MILD TR NO THROMBUS AND NO
PE MILD PULMONARY HYPERTENSION (37 MMHG)
MRI LUMBOSACRALSPINE NERVE COMPRESSION L4-L5, L5-S1
3507 WTDG COSEIP, PETER 78/M HERPES ZOSTER ASCVD PAROXYSMAL AF>SR HGB 114 WBC 7.6 PLT 169 DEFER AV DUPLEX
631155 ESRD SEC TO HTN NS HD 3/3
NON HEALING WOUND LEFT
LEG MEDS: VALACYCLOVIR 3/2;
S/P CVA? PIPTAZ 3/2

SIMVASTATIN, FENOFIBRATE,
CITICOLINE, TMZ WARFARIM
3510 LTAN UY, JULIET 69/F CAP-MR DCMP AF IN MVR HFREF NYHA 3/3 HGB 150 WBC 5.6 PLT 112 K 4.5 CREA 104 NA 131 IVF T/C
ELECTROLYTE IMBALANCE FCII
630681 NA 129 K 5.0 CREA 136
(HYPONATREMIA) WBC 4.4 HGB 148 PLT 154 SEG 84 REFER TO REHAB
HYPOTHYROIDISM
ECG: AF MVR ALB+ LASIX
S/P THYROIDECTOMY
CXR: STREAKY INFILTRATES RIGHT LLF MINTAZAPINE OD HS
(UNRECALLED)
MEDS: PANTO, THYROXINE,
CARNICOR, ELIQUIS, CAPTOPRIL,
DIGOXIN
NEW BUILDING
2604 LTAN JAYSON DACPANO CAPMR UTZ CHEST; PF 400CC RIGHT, LEFT 0 CBC NA K CREA 3/4
30/ M T/C PULMO MASS CEFEPIME
PLEURAL EFFUSION CREA 84 SGPT 118.5 NA 140 K 4.1 CSR PNM, PULMO MASS NOT RULED AZUITHRO
NAC COMBIVENT
PARAPNEUMONIC VS OUT
MALIGNANT PE HGB 131 WBC 7.6 PC ADEQ
2606 B ELT JUAN CHAVEZ 77/M CAP-MR HCVD ECG: NSR GALVUSMET
621181 COPD SUSPECT HGB 130 WBC 9.4 PLT 250 NA 136 K 3.6
BPH MEDS: AMLODIPINE, PIPTAZ
DMT2
2611A LTAN JOE DOMINGO 54M OBS PNEUMONIA SEC TO WBC 7.1 HGB 92 PLT 250 CREA 58 K 3.9
PULMO MASS EF 74% N LVD AND WT W/ AWMC, N PAP NO OBJ TO DISCHARGE
S/P BRONCHOSCOPY 3/1
2/28 PIPTAZO
2615 WTDG CHAN ELENA 83F CAPMR HCVD ACUTE AF MVR NYHA ARTERIAL: LEAD ATHEROSCLEROTIC WITH THICKENED AND CALCIFIED NA K ¾
DMT2 FC IIIC
630960 PAD RIGHT PROX-DISTAL PTA ARTERIAL WALLS. RLE 50-99% STENOSIS PROX TO DISTAL PTA,20-49% REER TO PULMO
STENOSIS CFA,DFA AND MID TO DISTAL SFA; LLE 20-49% STENOSIS DFA, SAMSCA URINOMEM
PRIX TO DISTAL SFA,PTA AND PRIX PERONEAL AND ATA, ABNORMAL ABI TELMISARTAN GLICLA CALTRATE
RIGHT DPA AND PTA SUGGESTIVE OF SEVERE ARTERIAL OCCLUSIVE DSE. SIIMVAS
DVT: NEGATIVE 2/28 PIPTAZO AZITH
3/1 NA 121 WBC 13.8 HGB 101 PLT 235 NA 106 K 4.3 CREA 59 PT EPO SAMSCA
12.6/1.02/79.6% HOLD ENOX
ECG AFR MVR CRBBB
ECHO: EF 76% STUDY DONE IN AFMVR, CONC LV REM W/ AWMC, GIANT
LA AND RA, MILD PE, MOD PULMO HTN

2617 TDY NICOLAS CO 83/ M CKD SEC TO DMN HCVD PREVIOUS NSTEMI 2/28 HGB 145 PLT 153 WBC 8.4 CREA 255 K 4.1 MGH
T2DM SEPT 2017 LANOXIN ASSAY NORMAL NO OBJ TO DISCHARGE
S/P HD 2/24; 2/27 PROB CAD, PAROXYMSAL WBC 5.7 HGB 149 PLT 157 NA 139 K 6.9 SGPT 52 BUN 47.6 CREA 837 ICA
S/P IJ RIGHT 2/24 AF> SR 1.09 PHOS 3.13 TOTAL PROTEIN 71 ALB 32 GLOBULIN 39 A/G RATIO 0.82 S/P HD 3/1
S/P PERM CATH INSERTION NYHA II PROTHROMBIN TIME 11.0 CONTR 11.2 INR 1.0 ACTIVITY 104% HOLD APIXABAN
3/1 SEVELAMER
EF 61% STUDY DONE IN AF IN SVR DILATED LV DIMENSIONS W/ NORMAL CLONIDINE AMLODIPINE
CONTRACTILITY AND SYSTOLIC FUNCTION DILATED LA ATHEROSCLEROTIC METOPROLOL – DIGPOXIN- W/
AORTIC RT W/ CALCIFIED PROXIMAL SEGMENTS AORTIC SCLEROSIS W/ OMISSION
CALCIFICATION AT THE MARGINS OF RCC AND NCC W/ O ROM BUT GEMFIBROZIL APIXABAN
TRIVIAL AR IS NOTED MITRAL SCLEROSIS W/ MILD MR, NO ROM, NO SAM, KETOSTERIL PAMTOP
AND NO PROLAPSE OF THE LEAFLETS NOTED ST N TV AND PV NORMAL RV IVILDAGLIPTIN
DIMENSIONS W/ NORMAL CONTRACTILITY NORMAL RA,MPA AND ARDS
NORMAL PAP W/ SPAP OF 23MMHG BY TR JET NO SHUNT ANOMALY NO
THROMBUS AND NO PE THE REST IF THE FINDINGS ARE UNREMARKABLE
2613 DBY ALFREDO PLANA 98/ ANASARCA HCVD 3V CAD S/P CABG 1998 HGB 104 WBC 5.9 PLT 182 NA 147 K 3.7 ALB 34 PEG INSERTION ON MONDAY
M HYPOALBUMINEMIA S/P PPI (DDD) 1998, S/P PGR LABS DONE AS OP (2/23/18): CREA 193 BUA 291 SGPT 26.9 ALP 151.67 PTPA 3/4
CHRONIC RENAL 2008 TOT PROT 56.19 ALBUMIN 22 GLOB 34 A/G 0.65 NA 138.06 K 3.41 2/28 CEFEPIME/CLINDA
INSUFFICIENCY NYHA FCIII HGB113/ 8.03/ S75/ PC 217 REFER TP NEURO
S/P CVA 2009 SEVERE CAROTID STENOSIS ECG: SR,1ST DEG AV BLOCK CITICOLINE
CAPMR D5NM X KVO
EF 60% CLOPI SAMSCA FURO PRN
NORMAL LVD W/ NORMAL WALL THICKNESS, NORMAL
SYSTOLIC THICKENING HOLD CORDARONE QTC 521
DILATED LA W/ LAVI IF 38.48ML/M2, DILATED RA, DILATED RV
DIMENSIONS
THICKENED MVLS W/O ROM
THICKENED AORTIC CUSPS W/ CALCIFICATIONS AT THE
MARGINS OF NCC W/ ROM OF NCC AND RCC
CALCIFIED AORTIC AND MITRAL CANNULU
NORMAL AORTIC RT W/ PLAQUES AT THE ANTERIOR AND
POSTERIOR WALL
NO EVIDENCE OF THROMBUS, NO PE
PACEMAKER WIRE BOYED AT THE R HEART CHAMBER
CFDS: RESTRICTIVE E/A PROFILE W/LAT E/E’ OF 23.7
INDICATIVE OF LV COMPLIANCE ABNORMALITY
MOSAIC CF ACROSS THE VALVES
MILD CALCIFIC STENOSIS W/ AVA OF 1.62 CM2 BY CE W/ MG
OF 6MMHG AND PG OF 12MMHG
PULMO ARTERY PRESSURE OF 38MMHG BY TR JET

CONCLUSION: NORMAL LVD W/ NORMAL LV DIMENSIONS W/


NORMAL SEGMENTAL AND GLIBAL SYSTOLIC FUNCTIIN W/
GRADE III DD
DILATED RV
BIATRIAL DILATATION
MITRAL SCLEROSIS W/ MILD MR
MILD AORTIC STENOSIS W/ AI +2
MODERATE TR
ATHEROSCLEROTIC AORTIC RT
MILD PULMO HTN W/ PR
2619 JSY EDUARDO TABISOLA HEPATIC ENCEPHALOPATHY DCMP CARDIAC 3/2 WBC 15.7 HGB 130 PLT 285 SEG 85 TOTAL BILIM SGPT SGOT PTPA
56/M SED TO ALD DYSRHYTHMIA ESR 71 AMONIA 39PRO CAL 5.60 CREA 268 NBE
LIVER CIRRHOSIS ACUTE AF IN 2/27 K 4.0 CREA 335
AKI RVR>>VFIB>>BRADY>> AF 2/25 CREA 349 WBC 9.9 HGB 150 PLT 126 K 3.9 ICA 1.07 MG 0.81 BLD CS
CELLULITIS RVR>SVT>NSVT>ST 2/22 NA 143 K 6 CKMB 92.3 CREA 243 ICA 0.98 MG 2.65 TROP I PT 20.4 REFER TO IDS
INR 11.2 ACT 37.3% APTT 35.7 VS 29.1 CRP 1.1 (ELEVATED) TRAMODOL
CHA2DS2VASC 0 HASBLED 2
ABG: UNCOMP MET ACIDOSIS MEDS: CARVED
NYHA FC III ECG: AF RVR AMIO TAB LANOXIN .125 OD>
T/C ACS FOR ARTERIAL DUPLEX OF UPPER EXTREMITY> NORMAL HOLD
OMEP, URSOMAX, LEGALON,
2/18 WBC 6.7 HGB 161 PLT 252 SEG 65NA 134 K 4.7 ALK PHOS 113 LACTULOSE, PROPRANOLOL,
TP 69 ALB 35 GLOB 34 A/G 1.03CREA 215 PT 15.1 INR 1.34 ACT 58.43 LASIX –HOLD
2/20 CREA 190 CLINDAMYCIN – HOLD

EF 14% STUDY DONE IN AFMVR, CLVH W/ SEVERE GLOBAL HK W/ ONLY


THE BASAL INFROLATERAL LVFW SHOWING SOME DEGREE OF
CONTARCTILITY , BIATRIAL DILATATION, MOD TO SEVERE TR, MOD
PULMO HTN

2620 ADC POLLY SY 60F MULTIPLE PHYSICAL INJURY HCVD WBC 9.9 HGB 123 PLT 255 NA 135 K 4.1 CREA 56 MGH
630912 SEC TO FALL ECG NSR AMLO ATENOLOL POLYNERV
COMMINUTED FX HUMERUS
L
S/P ORIF 3/2

2519 WTDG CUA, KIM YU 75/ M CPC NASAL POLYP BILATERAL HCVD 3V CAD S/P CABG 2009 HGB 135 WBC 6.38 PC 249 S 64 PMGH
S/P FESS 3/2 3/2 CEFU

2
2412 BGY EMELIA CHENG 81F CPC CAPMR 2/28 13.3 HGB 111 PLT 470 K 3.5 CREA 49 CBC SGPT SGOT PTPA PROCAL 3/4
629942 2/28 WBC 13 HGB 77 PLT 497 RESUME CLOPI
FRACTURE R HUMERUS
WBC 14.3 HGB 100 PLT 628 CREA 28 K 4.4 MEDS: ISMN ATENURIX TMZ
S/P BIPOLAR HIPPROSTHEISI HCVD PT 11.8/1.05/90.1% NEVOBOLOL SIMVAST GLIMEPERIFR
2/26
EF 60% N LVD W. AWMC, DIL LA RV, RA, MILD PULMO HTN AMLO LOSARTAN
2/20 PIPTAZO PUILMODUAL
2414 DBY CHUA GATI 88/ F 3/3 WNC 11.6 HGB 97 PLT 187 NA 159 K 3 CREA 140 DOPA 8CC/HR
3/2 TPAG: 46/22/24/0.92 CREA 312 K 2.8 ALB+LASIX KCL KLYTE
3/1 STUDY DONE IN AF IN MVR EF 73% CONCENTRIC LVH WITH NORMAL REFERRED TO URO
ELIQUIS –HELD 3/1
SEGMENTAL AND GLOBAL SYSTOLIC FUNCTION DILATED LA MITRAL
O2 AT 2 LPM
SCLEROSIS WITH MILD MR AORTIC SCLEROSIS WITH AI +1 MILD TR
2/25 CEFTRI >>> CEFEPIME 2/27
ATHEROSCLEROTIC AORTIC ROOT MODERATE PULMONARY PULMODUAL
CAPMR HCVD, CARDIA HYPERTENSION (59 MMHG)
CVA INFARCT RIGHT DYSRHYTHMIA SVT 2/28 WBC 15.1 HGB 103 PLT 120 AN 143 K 3.9 CREA 579 DEFER DISCHARGE
T2DM (ATRIAL FLUTTER W/ 2:1 CXR PROGRESSION OF INFILTARTES AMIO 2-2-2 X 5D THEN OD
HYPOTHYROIDISM BLOCK) ->PAROXYSMAL K 5.7 NA 138 PRIALTA
AKI SEC TO INFECTION WBC 13.4 HGB 141 PLT 77 SEG 83 APIXABAN DIGOXIN DEPAKENE
AF> NSR 2/23 NA 139 K 4.4 FBS 10.54 LEVOTHYROXINE ATORVASTATIN
2/20K 3 NA 138 AMLODIPINE METOPROLOL
ECG SR 1DAVB GLIMEPERIDE
CREA 56 CO MANAGED W/ NEURO
HGB 134 WBC 4.6 PC 193
NA 137 K3.6
CT SCAN ACUTE R POSTERIOR BASAL/ GLOBUS PALLIDUS CORONA RADIATA
2409 ELT RAON, ADELAIDA 83F COLON CA HCVD P CAD 3/3 CREA 84 NA 136 K 3.5
630912 BREAST CA ST II 2DED: EF 65%; N LVD W/ HK OF INF LVFW BASE TO MID W/ DERA, MILD NOR EPI 4MG X 10CC/HR-TAPER
CKD PROB SEC TO HTN KD MR AR TR, MILD PULMO HTN
ANEMIA PROB SEC TO MEDS: AMLO, CLONIDINE,
CHRONIC DISEASE LAXATROL, DULCOLAX KEPOX
S/P SIGMOID SX 3/1 METRONIDAZOLE,
ERYTHROMYCIN
2421 WTDG LAWRENCE TAN 62/ PROSTATE CA W/ ECG SR PSA NA CBC ¾
M BRAINMETS NA 131 CREA 67 2BC 9.5 HGB 112 NA 131 RADIOTHERAPY AFTER
CAPMR WITH ASPIRATION Mri:DESTRUCTION OF THE HIGH RIGHT FRONTOPARIETAL BONE DISCHARGE
COMPONENT ASSOCIATED WITH A 5X5X5.6CM EXTRA AXIAL (INTRACRANIAL) AND
S/P CHEMOTHERAPY SMALLER EXTRACRANIAL SOFT TISSUE COMPONENT, CONSISTENT WITH PIPTAZO
METASTASIS ASSOC MOD NEUROGENIC EDEMA AND RIGHT TO LEFT SHIFT CLINDAMYCIN
OF 1CM. THERE IS INVASION OF THE POSTERIOR ASPECT OF THE SUPERIOR TRIMETAZIDINE
SAGITTAL SINUS. ASSOCIATED MODERATE TO SEVER RIGHT LATERAL
VENTRICULAR COMPRESSION WITH MODERATE LEFT LATERAL
VENTRICULAR DILATATION AND TRANSEPENDYMAL EDEMA. MODERATE
CHRONIC SMALL VESSEL ISCHEMIA. FULL REPORT TO FOLLOW.
2319 MOG LIAM KIONG CO 82M TUBULAR ADENOMA HCVD PROB CAD WBC 16.6 HGB 158 PLT ADEQ NA 140 K 4.21 AWAITING U/A
S/P HEMICOLECTOMY 2/27 ECG SB NSTTWC
ECHO EG 60% N LVD W/ HK ENTIRE IVS AND INF LVFE FR M-A W/ OXYNORM DRIP
DERA,MILD MR, N PAP VENTOLIN NEB
METRO CEFU OXYCODONE
2320 RLIM JIMMY TAN 54/M CPC- R/O INCISIONAL HERNIA ECG: NSR DAT
631171 T2DM
S/P GASTRECTOMY 2012
S/P DIAGNOSTIC LAP 3/3
5A
1505 LTAN SIXTA CELIS 69F COLON CA W/ PROB PULMO CARDIAC DYSTRHYTHMIA Ct scan: bilat pna multiple mass , multiple enlarged ln incidental note of MGH IF OK W/ ALL AP
AND BRAIN METS ATRIAL FLUTTER>SR hepatic mets and adrenal mass COMBIFLEX 1.4 KCAL X 36HRS
CAP IN (40CC/HR) TC
IMMUNOCOMPROMISED 2/27 WBC 17.2 HGB 97 PLT 120 BANDS 4
O2 AT 2LPM
NA 125 K 3.5
MG 2.45 IVF: PNSS 500CC X+ 1 VIAL NACL
WBC 17 HGB 100 PLT 156 NA 130 K 2.6 ALB 16 ICA 1.12 MG 1.36 CKMB X 10CFC/HR
113 TROP 0.02
MEDS: CEFIPIME D3 LEVOX D2
2DED: EF 72% NLVD W/ AWMC, NRVD W/ NC; N LA, RA, MPA, ARDS, TH CALTRATE OMEP
AORIC CUSPS W/O ROM; TH AMVL W/O ROM W/ MILD MR; ST NORMAL
TV AND PV W/ MILD TR AND PR; NO T AND NO PE; MILD PULMO HTN
46MMHG
1506 LTAN TEODORO SERMON CAPMR HCVD LONG STANDING AF WBC 8 5.6 HGB 127 PLT 162 NA 137 CREA 81 K 3.8 ICA 1.21 MG 0.86 NO OBJ TO D/C
630387 81M MVR NYHA FC IIIC DIG ASSAY NORMAL
2/23 CLARITH DABIGATRAN
IRBESARTAN
2/25 MEROPENEM
HOLD LANOXIN
1508 LTAN TIAN CHONG C0 75/ HAP VHD SEVERE MR STAGE D WBC 5.8 HGB 121 PLT 110 NA 137 K 4.4 CREA 58 REFERRED TO ENT
639018 M T2DM SECONDARY TO FLAIL ANT ECG ST CRBBB IMMUNOPLUS
S/P PEG (2016) 7/17: 2DED EF63% DIL LVD W// NORMAL WT W/ HYPOKINESIA OF O2 4LPM VI ATM
S/P TRACH 2016, 2017
MVL W/ POSSIBLE
RUPTURED CHORDAE INFERIOR LVFW FROM BASE- APEX W/ DERA. DILLA. THICKENED ,MVL W/ LEVITERACETAM PRAZOLE VIT B
S/P CHANGE TRACH 2/13
PROB CAD, IN SR, FC II-III FLAIL ANTERIOR MVL W/ MOBILE ECHO DENSITY ATTACHED W/ SEVERE TAMSULOSIN XELEVIA NAC
MR CANOT R/O RUPTURED CHORDAE. MOD PR,MILD TO MOD TR. MILD 2/27 CEFTAZIDIME AMIKACIN
PULMO HTN APAP 41 MMHG
1509 HLC NGA YEE NGAN 82F 2/28 WBC 14 HGB 121 PLT 241 BLADDER TRAINING
WBC 22 HGB 127 PLT 299 BANDS 14 SEG 74 LYMPH 8 NA 135 K 3.6 CREA 49 ELTROXIN
CXR:PNA RLL
12L ECG: SINUS TACHY, NSSTWC 2/27 TAZO, LEVOFOXACIN, NAC
2/28 METRO OMEP
EF70%
AMEBIASIS
NORMAL LV DIMENSIONS AND WALL THICKNESS WITH
CAP-MR
ADEQUATE WALL MOTION ND CONTRACTILITY
SUBCLINICAL NORMAL RV DIMENSIONS W/ NORMAL CONTRACTILITY
HYPOTHYROIDISM DILATED LA
NORMAL RA,MPA AND ARDS
THICKENED MVL W/O ROM W/ MILD MR. EXTENSIVE MAC.
THICKENED AORTIC CUSPS W/O ROM
ST N TV AND PV W/MILD TR
NO THROMBUS AND NO PE
MILD PULMO HTN W/ SPAP OF 37MMHG BY TR JET METHOD
1510 ETH GLORIA ARCIAGA CAP-HR HCVD VHD SEVERE CALCIFIC ECG AF IN MVR PMGH 3/4
95/F S/P EXTUBATION 2/26 AS NYHA FC IIIC EF 69% TPEW AS, SEVERE CALCIFIC W/ ESTIMATED AVA OF 0.7CM2 BY CE
CARDIAC DYSRRHYTHMIA W/ PG OF 86MMHGVAND MG OF 49MMHG THICKENED AND CALCIFIED D/C O2 IN AM
PAROXYSMAL AF AORTIC CUSPS W/ ROM OF RCC AND NCC NCC IS NEARLY IMMOBILE W/ CXR 3/1
CHADSVASC 4 HASBLED 3 MILD AR. EXTENSIVE AACNORMAL LV CAVITY W/ HYPERTROPHIED WALLS RESUME CLOPIDOGREL
W/ ADEQUATE WALL MOTION AND CONTRACTILITY W/ DERA PROGRESSIVE DIET
DILATED LA THICKENED AMVL W/O ROM W/ MILD MR. MAC CANDESARTAN, LACIDIPIN,
ST N TV AND PV W/ MILD TR AND PR NORMAL PAP W/ SPAP OF 29MMHG METOPROLOL
ECG: ST DEP I, AVL 2/21 MEROP
REPEAT ECG: RESOLUTION OF ST DEP, PACS 2/24 LEVOX
TROP 0.14 WBC 11.5 HGB 117 PLT 166 DSEG 86 NA 135 K 4.0 METOPROLOL
U/A NORMAL
2/24 ENOS 0.2CC SQ OD
DVT: NEGATIVE FOR ACUTE DVT
1511 BSY/ JSY DR PARRRENO, T/C SEPTIC ARTHRITIS HCVD 3 V CAD S/P CABG ECG SR NSSTWC
FERNANDO 91/ M OSTEOARTHRITIS 1998 HGB 133 WVX 12,1 PLT 205 3/3 CLINDA/PIPTAZO
T2DM
S/P ARTHROCENTESIS 3/3 SILGRAM
TRAMADOL METOPROLOL ISMN
CLOPI-HELD
KETOANA NAHCO3 ROSU
TELMISARTAN
1514 LTAN PIMENTEL LUALHATI T/C SEPTIC ENCEPHALOPATHY 2/28 HGB 97 WBC 9.1 PLT 165 NA 146 UA PUS OVER 100 CBC NA K CREA 3/4
630675 90/F SEC TO CAP-MR, UTI ECG: NSR NA 149 2/28 PIPTAZO
PARKINSONS DSE K 4.3 SGPT 13 CREA 119 URINE CS
PT 12.8 INR 1.14 ACT 77.4 PIRACETAM
WBC 13.1 HGB 114 PLT 320 SEG 80 MEDS: TIDOMET, CITICOLINE
CLOPID, ROSUVASTATIN,
CALCITRIOL, CO AMOX,
CALMOSEPTIN
1515 ADC HECTOR CHUA 53/ M CPC APPENDICITIS HCVD 2/26 NA 134 K 4
S/P APPENDECTOMY 2/23 WBC 10.8 HGB 163 PLT 127 SEG 88 NA 131 K 3.9 BUN 7.1 CREA 87 DAT
CXR: CLEAR LUNGS WITH MAGNIFIED HEART, HAZINESS ON LEFT BASE DUE AMLODIPINE 10MG OD
TO SOFT TISSUE SUMMATION CETRIAXONE IV
ECG NSR METRONIDAZOLE IV

3
1517 WTDG CAROLINA SALAMAT THROMBOCYTOPENIA SEC HCVD, ACUTE AF IN 2/26 TRACHE CS: P. AEROGENOSA: LIGHT GROWTH DNR
TO INFECTION RVR>MVR, S/P ARREST 12/25 Crea 303 (264) Ecc 13 Hgb 98 (99) Hct 0.29 (0.29) Wbc 11.8 (11.7) D/C HD AND ALL MEDS
R/O MULTIPLE MYELOMA 2/9/17 Seg 71 (72) Lymphos 9 (10) Plt 140 (106) Na 134 (132) K 5 (5.1)
ACUTE INFARCTS IN THE LEFT 2/21 WBC 11.7 HGB 99 PLT 106 K 5.1 NA 132 Rpt cxr was done showing AC MODE 30%
RIGHT FRONTAL fluid on right lung with prominence of vascular markings compared to DNR
SUBCORTICAL WHITE previous, now with blunting of left cps CONT MEDS
MATTER, RIGHT CORONA 2/18: HGB 82 (91) WBC 15.4 PC 84 BANDS 5 NA 133 K 5.1 CREA 264 (395) HD 3/1
RADIATA, POSTERIOR LIMB PR 11.6 INR 1.04 ACT 93.2 APTT 29.7 2/28 PIPTAZO
OF BOTH INTERNAL 2/13 HGB 106 WBC 15.3 PLT 10 SEG 74 AMIKACIN
CAPSULE, AND RIGHT LONG TERM PLAN: FOR
HIPPOCAMPUS 2/13INITIAL MRI RESULTS SHOWED SMALL ACUTE INFARCTS IN THE LEFT DISCHARGE W/ MV IF UNABLE
SEPTIC SHOCK SEC CAP-HR RIGHT FRONTAL SUBCORTICAL WHITE MATTER, RIGHT CORONA RADIATA, TO WEAN
VS COMPLICATED UTI POSTERIOR LIMB OF BOTH INTERNAL CAPSULE, AND RIGHT
UREMIC ENCEPHALOPATHY; HIPPOCAMPUS; NEW SINCE MRI DARED 1/20/2018 SUBACUTE INFARCT
AKI PROB ON TOP OF CKD 2 INVOLVING THE MIDLINE MEDULLA CHRONIC INFARCTS INVOLVING THE 2/27 AMIKACIN
TO HTN NEPHROSCLEROSIS LEFT TEMPORO-PARIETO-OCCIPITAL LOBE AND RIGHT THALAMUS. 2/10 COLISTIN- D/C
VS DM NEPHROPATHY EXTENSIVE CHRONIC SMALL VESSEL ISCHEMIC CHANGES IN THE BILATERAL 2/10 IMIPENEM-D/C
ACUTE INFARCTION CEREBRAL WHITE MATTER. MILD TO MODERATE CEREBRAL VOLUME LOSS. AMIODARONE DRIP 10CC>
MEDULLA INTERVAL DEVELOPMENT OF BILATERAL MASTOIDITIS SHIFTED TO TAB
S/P IJ CATH L 2/6 2/13NA 131 (146) K 3.7 (5) HGB 106 (88HCT 0.31 (0.26 WBC 15.3 (43. AMLO 10MG-0-5MG
S/P REMOVAL OF IJ CATH BANDS 9 (29)SEG 74 (64)LYMPHOS 10 (4)PLT 10 (15) LANOXIN IV FULL DIG
S/P RIGHT FEM CATH 2/12 WBC 43.7 HGB 85 PLT 19 SEG 63 BANDS 20
INSERTION PTT 32.1
S/P TRACHEOSTOMY 2/22 MRI OF THE BRAIN SHOWED ACUTE MIDLINE INFARCTION OF MEDULLA
CHRONIC INFARCTS IN THE LEFT PARIETO-OFCUPITAL LOBE AND R
THALAMUS EXTENSIVE MICROVASCULAR ISCHEMIC CHANGES
CREA N 502MG/DL HGB 74 WBC 16.8 S 79 PC 169
NA 136 K 4.4 ECG SR, NSTWC
2DECHO: EF 77% NORMAL LV DIMENSIONS AND WALL THICKNESS W/
ADEQ WM AND CONTRACTILITY. DILATED LA. MILD MR. MILD TR.
NORMAL
1518 MOG HARRY GO 69/M ANEMIA PROB SEC TO HASCVD ISCHEMIC CMP 1 3/1 EXTRAMEDULLARY MASS CONUS MEDULLARIS VS WA CT SCAN PLAIN
LGIB SEC INT V CAD S/P PTCA DIRECT INTRAMEDULLARY MASS FROM CAUDA EQUINA. IMP PROB CORD REFER TO HEMA
HEMORRHOIDS STENTING PROX TO MD NEOPLASM EPENDYMOMA VS ASTROCYTOMA, CYSTIC NERVE
EXTRAMEDULLARY VS LAD 2016, PAROSYSMAL SHEATH TUMOR AND METASTASIS REFERRED TO REHAB
INTRAMEDULLARY MASS AF RVR NIF FC II B 2/28 EF 35% ECC LVH W/ GLOBAL HKW/ MARKED SYS DYSFXN AND
GR IIIDD, DIL LA RA, AORTIC SCLEROSIS W/ AI +2, MITRAL SCLEROSIS PAIN MANAGEMENT
W/ MR, MILD TRM MILD PULMO HTN REFERED TO NEURO
PROV ECH0 EF 40% GLOBAL HK REFERRED TO NEURO SX
AFRVR 122 LATERAL WALL ISCHEMIA REFERRED TO ORHTO
CREA 141 SGPT 21 WBC 11.4 HGB 100 HCT 0.304 PLT 133 NA 132
K4.2 ICA 1.28 MG 2.07 MEDS: AMIODARONE 600
MG X 10 CCHR TO CONSUME
AT 8 PM 2/26 THEN START
AMIO TAB BID
DOLCET, LYRICA
ASA/CLOIPID-HOLD
IRBESARTAN RANITIDINE
FACKTU
1520 WTDG ZACARIAS MENDOZA CVA INFARCT LEFT HCVD 2/24 WBC 6.8 HGB 107 PLT 254 SEG 60
630148 65/ M UGIB SEC TO DU CREA 124 K 3.9
UTI 2/23 HGB 110 WBC 7.9 CREA 271 FOBT (+) CBC 3/4
S/P SHOCKWAVE ECG SR NSTWC REFERRED TO REHAB
LITHOTRIPSY FOR NA 137 K4
NEPHROLITHIASIS 1960’S CREA 116 RESUME CLOPI 2/27
UGIB HGB 101 WBC 14.9 PC 280 SOFT DIET
S/P EGD 2/22 DUODENAL CT SCAN: ACUTE-SUBACUTE INFARCT L INSULA HOLD ASA/CLOPI
ULCER VENOUS DUPLEX: NEGATIVE FOR ACUTE DVT BOTH LOWER EXT ARTERIAL S/P 1 U PRBC BT
DUPLEX: <50% STENOIS ON MOST ARTERIAL SEGMENTS BOTH LOWER EXT
CAROTID DUPLEX: <50% STENOSIS B ICA, B CCA AND INSIGNIFICANT PANTOP MUCOSTA
STENOSIS B ECA N ANTEGRADE FLOW B VERT ARTERY FLOW CEFTRIAXONE, AZITH 2/19
PLSIN CT SCAN
AMLODIPINE, AZITH

OMEPRAZOLE
1521 LTAN DOROTEO ABOY 89M CPC- CAP-HR HCVD 2/27 WBC 7.9 HGB 107 PLT 222 NA 135 K 3.7 CREA 83 CXR ABG 3.4
CVA INFARCT L OCCIPITAL, WBC 9.7 HGB 95 PLT 189 SEG 77 PMGH 3/6
LACUNAR INFARCT REFERRED TO NEURO
CKD SEC TO DM KD VS HTN CREA 112 K 3.5 NA 133
KD HOLD GLICLAZIDE
DMT2 PT 10.8 INR 0.96 ACT 108% CASTOR OIL
S/P TRACHEOSTOMY 2/28 IVF PLR 500 X20CC/HR

TRACHE MASK AT 2 LPM


ELIQUIS
START NATRIXAM
D/C AMLODIPINE
1523D WTDG/RA BASILIO DIAZ 77/M CKD HCVD BRADYARRYTHMIA CREA 330 K 4.2 NA 137 AMLODIPINE
MIREZ DEMENTIA A AA MEDS: SEROQUEL, CLOPID,
WBC 5.8 HGB 97 PLT 153 SEG 56 CLONIDINE, HERACLENE,
S/P CVA INFARCT MAY 2017 KETOANALOGUE,
PTB CLINICALLY DIAGNOSE DOMPERIDONE, ATORVASTATIN,
COPDNIAE LEVETERACETAM, FERBUTALINE,
MIRACOLINE, RESINCAL-HOLD,
COMBIVENT, NAC, WEPOX
1528 LTAN ENRIQUEZ ELPIDIO HAP HCVD 3/3 WBC 58.2 HGB 92 PLT 165 SIMV 40%
623068 106/M SAH SEC TO FALL WITH 2/28 WBC 54.4 HGB 100 PLT 45 NA 137 K 4.6 CREA 222 NORTHIX SC X 15 CC/HR TAPER
9 SUBFALCINE HERNIATION WBC 23.6 HGB 102 PLT 98 NA 136 K 4.3 CREa 148 MIDAZOLAM DRIP CONSUMED
RIGHT CT SCAN: LEFT PARIETOTEMPORAL LOBE W/ COMPRESSION EFFECT LEFT 2/28 PIPTAZO
KEPPRA MANNITOL
LATERAL VENTRICLE; SAH LEFT FRONTOPARIETAL REGION, MIN SAH R
LEVOFLOXACIN
TEMPORAL; SUBFALCINE HERNIATION RIGHT, SCALP HEMATOMA RIGHT S/P BT 4U PLT CONC
FRONTOPARIETAL, SOFT TISSUE SWELLING RIGHT PARIORBITAL AND FOR BT 4 U PLT CON, 2 U PRBC
MAXILLARY AREA
MEDS: AMLO, ROSU, TRANEX,
NA 138 K 4.5 MANNITOL, PANTO,
WBC 8.9 HGB 67 POLT 23 SEG 89 LEVETERACETAM, DEXA
1544 ADC ROMEL SIOSON 52/M AGE HCVD 3 VESSEL CAD; S/P CA WBC 8.7 HGB 140 PLT 237 SEG 66
631166 T2DM 7/8/17; S/P CABG 4V GRAFT MEDS: CIPRO, ASA, ATORVASTATIN,
1 AKI ON TOP OF CKD PROB NA 134 K 5.0 CREA 391 GLIMIPERIDE, ATENURIX,
JULY 2017;
SEC TO DM KD METFORMIN, ALDAZIDE, LINAGIPTIN
HFREF NYHA FC II

1548 ADC ANGELES CVA INFARCT HCVD HGB 154 WBC 9 PC 174 CITICHOLINE
FREDESMINDA CREA 57 K 3.7 TELMISARTAN ASA ATORVASTATIN
EF 67% N LVD AND WT W/ AWMC N RVD W/ NC N LA, RA, MPA AND ARDS PANTOPRAZOLE
THICKENED MVLS W/O ROM WITH MILD MR; MAC THICKENED RCC AND
NCC W/O ROM; AAC N TV AND PV WITH MILD TR AND MILD PR NO
THROMBUS AND NO PE N PAP
4A
1401D ASY RANOY DOMINGO SEPSIS SEC TO SKIN AND 2DED: EF 41%; CLVH W/ HK ENTIRE LVS AND INF WALL BASR TO APEX AND COMPLETE ANTIBIOTICS FOR 14
630020 49/M SOFT TISSUE INFECTION INFEROLAT LVFW MID TO APEX. SLT DIL LA. N PAP DAYS
RIGHT LEG; T/C
NECROTIZING FASCITIS VS ECG: ST, NSSTWC
KLYTE
INFECTED PSORAIASIS ASCVD PROB CAD NYHA FC II WBC 8.7 HGB 129 PLT 120 TMZ
PLAQUE ISOKET DRIP 10 CC/HR
BANIAE, OSA NA 134 CREA 52 K 3.6 CLINDA
S/P DEBRIDEMENT AND CEFTRI
FASCIOTOMY 2/25
S/P DEBRIDEMENT 2/28
1401C LTAN VICTOR TAMAYO 58/M 2DED: EF 75%; N LVD W/ AWMC AWAITING LABS
631153
CPC- FISTULA IN ANO CXR: N FOR FISTULECTOMY 3/3 10 AM
ECG: SB CLEARED

1402 ADC CRISANTO UDQUIN NON HEALING WOUND LEFT 2/25 HGB 110 WBC 13.7 PLT 416 CREA 76 MEROP AND VANCO COMPLETED>
629744 59M FOOT HCVD 3V CAD S/P CABG 2005 2/21 WBC 16.7 HGB 111 PLT 437 NA 137 K 4.1 CREA 77 ICA 1.14 MG 0.72 CRP 18.8 DOXYCYCLINE 2/26
NYH AFC IIIC ECG ACCELERATED IDIOVENTRICULAR RHYTHM DAT
S/P I AND D 2/13

4
S/P DISRT 2ND TOE 1/10/18 LANTUS ENTRESTO FURO ATOR
T2DM FENOFIBRATE CLOPI CILOSTAZOL
S/P CVA 2005 DIGOX COLCHICINE
S/P DISARTICULATION 1ST AND
3RD TOE 2/23

1404 ELT OSILLOS MARIA 72F AWAITING LABS


COMPLICATED UTI HCVD PROB CAD
PROGLIMET CLONIDINE CLOPI
DMT2 S/P PPI 2013 SEC TO SSS? TELMI GLICLA NEVIBOLOL
1407 LTAN CHI SO JR. 68/M EF 57% CONC LVH WITH HYPOKINETIC ENTIRE IVS AND INFERIOR WALL AWAITING LABS
631150 BASE TO APEX N RVD AND N CONTRACTILITY DILATED LA N RA MILD TR NO
CPC- LEFT SHOULDER THROMBUS AND PERICARDIAL EFFUSION N PAP (22MMHG) COMPARE FOR SURGERY ON MONDAY NO
HCVD CAD S/P CABG 2008
FRACTURE/ DISLOCATION LONG STANDING AF NYHA FC II WITH PREVIOUS MODERATE TR INCREASE PAP 53MMHG FROM 48MMHG TIME YET
T2DM
MEDS: CLEXANE T/S 3/3
PRADAXA- HOLD 2/28
1411 HLC LIODA MANALILI 59/F AKI SEC TO HYPERCALCEMIA WBC 18.7 HGB 97 PLT 32 S/P HD 2/26
629287 SEC TO MALIGNANCY OF MEROPENEMN
(PROCEDURE) UNKNOWN PRIMARY
T/C PANCOST TUMOR
T/C LUNG CA VS THYROID
S/P FEM CATH INSERTION
2/15 RIGHT
1418 RLIM ROMANA REYES 91/ F CAPMR HCVD CARDIAC 3/2 WBC 2.7 HGB 99 PLT 9 SEG 67 NICARD DRIP X 15CC/HR
AKI DYSRRHYTHMIA SVT> SR>> NA 123 K2.6 HGB 90 WBC 1.9 S 77 PC 131 AMLO
UGIB 2 TO ANGIODYSPLASTIC AF RVR CREA 144
COLON ECG ST ADENOSISNE 6-12 AND
T2DM VERAPAMIL GIVEN
CEFEPIME LINAGIPTIN
PREDRISONE OMEPRAZOLE
1419A ELT JOSEBELL BEIN 56M CELLULITIS R LEG HCVD PROB CAD 2/28 CREA 104 NA 138 K 3.7 HGB 113 PLT 345 WBC 12.1 PMGH 3/3
630751 AKI EF 66% NORMAL LV DIMENSIONS W/ HYPERTROPHIED WALLS W/ AMLODIPINE
ADEQUATE WALL MOTION AND CONTRACTILITY NORMAL RVD W/ PIPTAZO/CLINDA
NORMAL CONTRACTILITY DILATED LA W/ LAVI OF 24.13ML/M2. NORMAL ASA DOLCET
RA,MPA AND ARDS THICKENED RCC W/O ROM THICKENED AMVL W/O
ROM W/MILD MR ST NORMAL TV AND PV NO THROMBUS AND NO PE
NORMAL PAP W/ SPAP OF 29MMHG BY TR JET METHOD
WBC 17.5 HGB 13 3PLT 242 NA 136 K 2.9 CREA 228
ECG SR NSTTWC
Dvt: Negative for DVT both lower exts
1419B RUALES MALANUM ROGELIO NON HEALING WOUND L ADHF HCVD 3V CAD S/P LEAD, ATHEROSCLEROTIC W/ DIFFUSELY THICKENED & CALCIFIED BT 1 PRBC
630996 72M FOOT CABG 2004 NYHA FC IIIC WALL:RLE: NTO OF THE MID TO DISTAL SFA, TPT TO D PTA W/
DMT2 PAD RIGHT NTO MID TO RECONSTITUTION OF FLOW INTO THE MITRAL SFA VIA COLLATERALS, CARVEDILOL
AKI ON TOP OF CKD DISTAL SFA, TPT TO D PTA, >75% STENOSIS OF THE PROX TO D PERONEAL, PROX TO D ATA W/ DPA,
S/P CVA 2014 NO RESIDUALS PROX TO D PERONEAL, PROX 50-99% STENOSIS AT THE CKA, DFA & POP,> 2/28 PIPTAZO
TO D ATA W/ DPA, CKA, DFA 75% STENOSIS AT THE PROX TO D SFA, DISUSAL POP & DPA,50-99% CLEXANE
& POP STENOSIS AT THE REST OF THE ARTERIAL SEGMENTS,ABI NOT DONE DUE REFER TO NEPHRP
SUBACUTE TO CHRONIC DVT TO THE GANGRENE & BLISTERS AT THE LOWER EXTREMITIES.,DVT ASA ATOR EDEMANN PLETAAL
BILATERAL PTV AND R SOLEIL SCREENING,POSITIVE FOR DVT POSSIBLY SUBACUTE TO CHRONIC , AMLO METFORMIN ENOX
VEIN BILATERAL PTV AND R SOLEAL VEIN AMLODIPINE
WBC 14.6 HGB 86 PLT 233 NA 136 K 3.7 CREA 315 BUN 31 DDIMER 3.60
ECG SR CRBBB
1419C WTDG HENRY TIU 55/ M PNEUMOTHORAX L HCVD PROB CAD HGB 145 WBC 6.28 PLT 259 CREA 60 NA 142 K 4.25 CHEST HRCT
TONGUE CA S/P CHEMO AND NOV 2017 Post excersie treadmill echocardiogram showed hypokinesia of
RADIOTHERAPY SEPT 2017 the distal half of the inferior and inferolateral left ventricular free wall at DAT
S/P CTT 2/28 stage 3 exercise which returned to baseline at 3mins recovery period AMLO ISMN TMZ
Serial treadmill stress electrocardiogram showed 1-2nm st depression in II
III AVF V3-V6 during stage 3 which returned to baseline at recovery period. RETRIEVE LABS DONE AS OPD
Occasional premature ventricular contractions occurring singly in noted
exercise
abnormal treadmill stress echocardiogram w ith stress induced wall
motion abnormality noted at 10.2 mets involving the distal half of the
inferior and inferolateral left ventricular free wall Abnormal treadmill
stress electrocardiogram at 10.2 mets

2/27/18 EF63%
NORMAL LV DIMENSIONS AND WALL THICKNESS WITH
ADEQUATE WALL MOTION ND CONTRACTILITY
NORMAL RV DIMENSIONS W/ NORMAL CONTRACTILITY
DILATED LA W/ LAVI IF 25.05ML/M2
NORMAL RA,MPA AND ARDS
THICKENED MVL W/O ROM W/ MILD MR
THICKENED RCC W/O ROM
ST N TV AND PV W/MILD TNI THROMBUS AND NO PE
NORMAL PAP W/ SPAP OF 19MMHG BY TR JET METHOD

COMPARED W/ PREVIOUS 2DECHO DONE LAST 11/16/17: NO


SIGNIFICANT CHANGE
1422 LTAN LAWRENCE CHUA CELLULITIS L FOOT W/ HCVD PROB CAD SR NYHA FC 2/28 CREA 65 K 4.7 HBOT 10 SESSION
628098 53M GRANGRENOUS BULLAE IIIC 2/20 HGB 114 WBC 13.8 S 81 PC 492 2/28 CLINDA/LEVOX
PLANTAR SURFACE W/ PAD, BILATERAL 2/15 WBC 20.6 HGB 127 PLT 552 SEG 86 2/19 LEVOX
ABSCESS CREA 71 NA 131 K 4.6 S/P HBOT
DMT2 2/13 HGB 117 WBC 22.3 PLT 470 NA 129 K 4.3 CREA 57 2/15 UNASYN
S/P DEBRIDEMENT 2/6, 2/12 BLD CS NEGATIVE HOLD CLEXANE
S/P DEBRIDEMENT AND ECG ST ASA
SIARTICULATION OF 2ND 2/4 ECHO: EF 57% N LD W/ NWT W/ HK ANT IVS FR B-A, DIL LA, TRIVIAL PIPTAZO CLINDA>> METRO-D/C
METATARSAL LEFT FOOT MR, MILD TR, N PAP (16MMHG) VALSARTAN ATOR VIT K INSULIN
2/24 RLE: >50% STENOSIS PROC PTA, POST PERONEAL, PROX-DISTAL ATA LLE: ISMN LANOXIN CLEXANE
>50% STENOSIS FEMORAL A, DISTAL TIBIOPERONEAL, PROX POST TIBIAL COD 2/15
AND PROX AND DISTAL ANTERIOR TIBIAL
1423 ADC LADIOS, TERESITA SECOND DEGREE BURN 2 TO ASCVD CARDIAC ARRHYTMIA 2/16 NA 136 K4.4 ICA 1.26 MG 0.77 BED SIDE DEBRIDEMENT MARCH
626314 69/F FLARE INJURY ( TBSA 36%)\ PVC IN BIGEMENY >> SR 2/14 CREA 48 NA 124 K4.4 HGB 97 WBC 9.2 PC 356 58 4/5
S/P DEBRIDEMENT 12/29, NYHA FC I 1/25 HGB 100 WBC 7.2 PLT 449
12/31, 1/3, 1/6,1/9, 1/3, 12/20 ECG : SR, 1ST DEG AV BLOCK ERTAP AND MICAFUNGIN
1/22, 1/26, 1/31 NA 140 K4.2 SGPT 29 SGOT 40 CREA 82 MG 1.75 ICA 1.16 COMPLETED
S/P FEM CATH INSERTON HGB 113 WBC 9 PC 191 DAT
RIGHT 12/29 PT 10.4S INR 1 ACT 117% MEDS: AMIO TAB
S/P REMOVAL OF FEM CATH EF 70% AWMC N PAP TRAMADOL OMEP
2/4 HOLD PEPTAMEN
S/P DEBRIDEMENT 2/5,2/10, CIPRO
2/20
S/P IJ CATH 2/8

1445 A LTAN GLORIA PASOBILIO CALLOUS L SOLE HGB 127 WBC 4 PC ADEQ MGH 3/3
67/ F S/P EXCISION OF CALLOUS
AND DEBRIDEMEN L SOLE
3/1
1446B BORBE MILAGROS OSORIO UGIB PROB SEC TO BPUD SEC HASCVD NSTE ACS NIF FC IIB 2/28 WBC 9.1 HGB 124 PLT 222 SEG 75 AMPICILLIN SULBACTAM
81/F TO CLOPIDOGREL AZITH
CREA 80 K 3.7 SOFT DIET
2/26: HGB 109 WBC 14.3 SEG 87 LYM 6 PC 259 NA132 K 4.3
IVF: D5NSSS 1L X KVO
NA 130 K 3.7 SGPT 13 CREA 108 CKMB 23 (NORMAL) TROP I 0.33 S/P BT 1 U FWB AND 1 U PRBC
(ELEVATED) 2/26
ANTEROLATERAL WALL ISCHEMIA
IVF: PNSS + 20 MEQS KCL 20CC
ECHO: EF 17% NLVD WITH SEVERE GLOBAL HYPOKINESIA W/ AKINETIC VOLUVEN 10CC/HRCC
SEPTUM AND WHOLE APICAL SEGMENTS. ONLY THE BASAL INF AND PANTOPRAZOLE 80MG X 10CC
INFEROLAT LVFW SHOWING SOME DEGREE OF CONTRACTILITY W/ GRADE
2 LVDD; DILATED RVD W/ HYPERTROPHIED WALLS; DIL LA W/ LAVI
32ML/M2; NORMAL RA, MPA AND ARDS W/ CAPAWS; TH AO CUSPS W./O
ROM W/ MOD TO SEVERE MR; W/ WIDENED EPSS SUGGESTIVE OF
ELEVATED LV FILLING PRESSURES; TH TV W/ MOD TR AND MOD PR; NO T
AND NO PE NOTED; MILD PULMO HTN 47MMHG PAP
1448B ASY HERMINIA SABADO NON HODGEKINS HCVD 2/28 ANTI EMBOLIC STOCKING
72/F LYMPHOMA ACUTE TO SUBACUTE DVT
MALIGNANT ASCITIS RIGHT SOLEAL VEIN WBC 10.7 HGB 99 PLT 274 MEDS: LOSARTAN, TRAMADOL,
SECONDARY NA 139 K 4.1 CREA 94 PANTO, PRED, ALLUPURINOL,

5
PLEURAL EFFUSION AROXIA, NAC CIPRO,
BILATERAL; S/P 2DED: EF 63% MEDTRONIDAZOLE
THORACENTESIS 2X N LVD W/ AWMC; DIL LA AND RA; MILD MR, TR, MILD PULMONARY
HYPERTENSION
1309 LTAN MARY FLORENCE UTI WBC 12.7 HGB 94 PC 145 S 89 LEVOTHYROXIN
SANTILLAN 29/ F HYPOTHYROIDISM K 3.2 KLYTE
‘G1PO 35 WKS AOG UA PC 506 ESR 35 3/2 CEFTRIAXONE
ECG SR W/ OCC PVC

TELE

ICU
ICU1 LTAN ONG SIOK BI 89/ F CAP HR ASCVD SEVERE CALCIFIC AS 2/28 CREA 192 TP 61 ALB 23 GLOB 38 A/G .61 ICA 1.24 MG .69 NA 147 O2 2 LPM
ARF 2 S/P PPI 2007 FOR TACHY- K 3.4 WBC 9.2 HGB 99 PLT 148 SEG 82 AMINOPHYLLINE 5CC/HR
T/C UREMIC BRADYARHYTMIA 2/26 U/A PUS 1-2 RBC 15-20
ENCEPHALOPATHY S/P PGR 2017 2/25 WBC 12.3 HGB 105 PLT 115 CREA 348 K 2.9 NA 144 URINE CS MEDS: , ALBUMIN,
COMPRESSION FRACTURE NEGATIVE CEFIPIME 2/20,
DEFORMITY T1, L3 2/22 WBC 16.7 HGB 110 PLT 152 CREA 577, NA 143 K 3.9 ICA 1.19 2/26 FLUCONAZOLE,
DISC SPACE DISEASE 2/21: K 5.9 CREA 645 2/28 CLINDA
T2DM CREA 620 K 6.5 NA 136 HGB 108 WBC 12.7 S 90 PC 177
AKI ECG AF IN MVR INSULIN GLARGINE
S/P EXTUBATION 3/2 SGPT 17 PT 13.6 INR 1.21 APTT 29.4 S FURO, SITAGLIPTIN,
EEG: GENERALIZED SLOWING ROSUVASTATIN, CITICOLINE,
ECHO: EF 75% NLVD WITH AWMC, SEVRE CALCIFIC AS WITH AVA OF 0.77 PREGABALIN, NAHCO3 TID
PG 57MMHG MG 33MMHG MOD PULMO HTN (PAP 62MMHG) TERBUTALLINE
CALCIUM GLUCONATE
SALB NEB INSULIN
HOLD DOLCET
AMIO VERAPAMIL

ICU 4 ADC ALEXANDER TAN ARF SEC TO COPD SEC TO HCVD Dvt screening negative FOR TRACHESTOMY 3/3 11AM
(PROCEDUR 70M CAP-HR 2/27 WBC 12.4 HGB 125 PLT 145 SEG 84 CREA 852 K 6.2 PT 10.7 INR 1.0 AC MODE FIO2 50%
E) AKI SEC TO DEHYDRATION VS ACT 110% APTT 33.0 2/24 MEROPENEM
SEPSIS
S/P R FEM CATH INSERTION
2/28
ICU6 LTAN ALMA UY UGIB GI PROB SEC TO HCVD ECG: ST S/P BT OF 2U PRBC
BLEEDING VASCULAR CXR: CARDIOMEG
ECTASIA VS VARICEAL BLEED WBC 21.2 HGB 62 APC 139 CREA 56 ALT 36 ALB 30 NA 133 K 4.7
HEP C INFECTION
ICU 5 DBY FELICIANO AYROSO PLEURAL EFFUSION PROB HCVD, LONG STANDING AF 3/2 wbc 13.8 HGB 102 PLT 25 SEG 88 NA 137 K 3.9 ALB 31 CREA 102 FOR UTZ GUIDED THORA 3/3
82/ M PARAPENUMONIC VS CHA2DS2VASC 4 HASBLED 2 PTPA 21.6/11.2/1.90/34.5% AC MODE 30%
PULMO METS CHRONIC DVT LEFT Dvt Negative of bilateral le w/ complete recanalization o fthe previously 3/1 FLUCONAZOLE
NEUTROPENIA SEC TO PROXIMAL TO DISTAL occluded prox to distal popliteal vein 2/28 MEROPENEM
CHEMO POPLETEAL VEIN WITH 3/2 UTZ of hemithorax Free fluid is seen on both hemithoraces with
RECANALIZATION OF RIGHT approximate volumes as follows: R: 861 cc L: 500 cc Associated REFER TO IDS, ONCO, GASTRO
AGE W/ SOME SIGNS OF
POSTERIOR TIBIAL AND subsegmental atelectasis is noted in both sides FILGRASTIM
DHN PROXIMAL VEIN ISOMIL Q6
HIGH GRADE HODGKIN Utz of the WA - Minimal ascites - s/p cholecystectomy - Prominent
LYMPHOMA, DIFFUSE LARGE common bile duct (1.5 mm) probably due to post cholecystectomy state ERCEFLORA HIDRASEC
B CELL TYPE, S/P EXLAP - Bilateral renal cortical cysts measuring: > left upper pole: 0.87 x 0.67 mm AMIO, XARELTO, ALDACTONE
ANEMIA PRO SEC TO > left lower pole: 0.84 x 0.69 mm > right lower pole: 1.51 x 1.80 mm
MALNUTRITION - Underfilled urinary bladder precluding evaluation of prostate gland
UTI Cxr: bilateral pulmo congestion w/ prog of infiltrates
HYPERCALCEMIA PROB SEC 2/26 HGB 104 WBC 12.3 MYELO 1 METAMYELO 1 B 26 S56 PC 157
TO MALIGNANCY NA 134 K2.92/25 HGB 110 WBC 14.1 PLT 73 NA 131 K 3.4
2/24 WBC 2.9 HGB 86 PLT 25 BANDS 20
S/P CHEMO CHOP 2/11
NA 131 K 2.6 TROP I 0.04 CKMB 7.1
2/22 NA 123 K 2.3 ALB 21 WBC 0.6 GGB 77 PLT 42
2/21 NA 130 K 2.3 CREA 125 BUA 170
2/20 CXR PNEUMONIC PROCESS IN RLLL, FIBROTIC SCARRING BUL W/
BILATERAL APICAL PLEURAL THICKENING
FA NEG
PET SCAN: EXTENSIVE FDG-AVID ABDOMINO-PELVIC DISEASE( CONSISTING
OF PERITONEAL/MESENTERIC/POSSIBLY OMENTAL LEAIONS, AND
MULTIPLE LYMPH NODES UP TO THE INGUINAL REGION) IS LIKELY
LYMPHOMATOUS IN ETIOLOGY, GIVEN THE CLINICAL DATE. THE
CONTRIBUTION OF POST-SURGICAL INFLAMMATION( FROM THE PRIOR
SURGERY) TO THE ABDOMINAL FDG UPTAKE CANNOT BE ASCENTAINED.
FFH-AVID LYMPHADENOPATHY IN THE CHEST( INVOLVING A FEW NODES
IN THE MEDIASTINUM AND ONE IN THE RIGHT HILUM) IS SUSPICIOUS FOR
LYMPHOMATOUS INVOLVEMENT( VERSUS INFLAMMATORY)
ICU7 RLIM DR. CARLOS HERRERA UGIB HIE SEC TO CP ARREST (5EPI) 3/1 WBC 18.3 HGB 93 PLT 381 SGPT 39 SGOT 65 OFF INOTROPES
630976 60/M ESRD SEC TO DKD HCVD PROB CAD HFREF 2/28 HGB 78 WBC 15.4 PLT 314 NA 130 K 4.5 CREA 382 ICA 1.20 MG 0.89 CBC NA PRE HD
S/P AVF CREATION 1/26 PAROXYSMAL AF>NYHA FC II PT 23.2/2.01/31.3% SLED 3/3
T2DM PAOD B LE
LOWER EXT ARTERIAL DSE WITH MULTIPLE CALCIFIED PLAQUES WITH: RLE: D5NSS X 20 CC/HR
>50% STENOSIS OF PROX TO DISTAL PERONEAL AND MID TO DISTAL ATA INSULIN DRIP AT 4U/HR
<50% STENOSIS OF THE PROXIMAL TO DISTAL SFA, DISTAL POST SFA, TPT,
PROX TO DISTAL PTA AND DP LLE: >50% STENOSIS OF THE MID TO DISTAL 3/1 MEROPENEM
ATA AND DPA <50% STENOSIS OF THE MID TO DISTAL SFA LEFT POPLITEAL ENTRESTO CITICOLINE DEXA
AND PERONEAL ARTERY NOT VISUALIZED DUE TO BANDAGED WOUND PANTOP
DEPAKENE
1/19 EF 42% DILATED LV W/ NWT W/ THINNED OUT AKINETIC BASAL LV
SEGMENTS EXCEPT FOR THE INF IVS WHICH IS MODERATELY HYPOKINETIC. HD 3X /WK
THE REST OF THE LV SEGMENTS ARE SEVERELY HYPOKINETIC W/ GRADE
2DD DILATED RV W/ NC BIATRIAL DILATATION N MPA AND ARDS W/ HYPOTHERMICPROTOCOL AT
CALCFIED ANT AND POST AORTIC WALLS THICKENED MVLS W/O ROM W/ 36C
MILD MR; MAC THICKENED RCC AND NCC W/O ROM W/ MILD AR ST N TV
AND PV W/ MILD TR NO THROMBUS OR PE MILD PULMO HTN (46MMHG)
CWPS DONE ¼/18 EF DECREASED FR 46% TO 42% WORSENED SEGMENTAL
WALL MOTION ABN GRADE 2DD IS NOW NOTED DILATED RV

ICU9 LTAN RODOLFO DE LARA CVA POSTERIOR, INFERIOR HASCVD 1 V CAD S/P PTCA CRANIAL CT SCAN: RESOLUTION OF HYDROCEPHALUS, REGRESSION OF FOR TRACHE 3/3 9:30AM
58/M CEREBELLAR INFARCT 2002 DISTAL LAD NIF IN SR SUBEPENDYMAL EFFSUION, UNCHANGED EDEMA
UTI FC IIB 3/1 HGB 89 WBC 16.3 PLT 332 NA 133 K 4 CREA 88 NORTHIX 4MG X 14CCHR
UGIB SEC TOGASTRIC ULCER ACS STEMI ANTEROSEPTAL 2/24 WBC 17.7 HGB 98 PLT 322 K 3,8 NA 150 H20 DEF 2.7 L
ANTRUM FORREST IIA-IIB S/P WALL, KILLIP 4 2/23 WBC 12.5 HGB 108 PLT 265 SEG 79
INJECTION SCLEROTX NSVT> SR >ST (2/18) MV SETTINGS: AC, FIO2 35%
2/16/18 CREA 108 NA 148
S/P REPEAT EGD 2 LARGE 2/21: WBC 16.6 HGB 109 SEG 74 PC 284 NA 152 K 4.5 CREA 143 TP 62 ALB MEDS:
GASTRIC ULCER WITH VISBLE 35 ICA 1.17 MG 0.96 AMMONIA 20 CORALAN, BACLOFEN
VESSEL PANTOPRAZOLE, POBVENTA,
S/P E’ EXLAP WITH LIGATION 2/18; ICA 1.11 MG 1.82 MG/DL NA 145 K 3.5 ALGESIA TAB Q8
OF BLEEDER 2/17 HGB 102
S/P POSTERIOR FOSSA 2/16 CREA 98 K 5.9 NA 138 WBC 21.8 HGB 87 HCT .264 PLT 305 BANDS 1 MEROP >> CEFEPIME 2/26
DECOMPRESSION 2/25 SEG 89
SR LAE LAD PRWP NSSTWC
CXR: PROGRESSIO0N OF PNEUMONIC INFILTRATES R, MINIMAL
REGRESSION OF CONGESTION LEFT
ECHO; EF 38% GLOBAL HYPOKINESIA
CT SCAN: 2/23/18: NO SIGNIFICANT INTERVAL CHANGE IN THE DEGREE OF
EDEMA IN BILATERAL POSTERIOR INFERIOR CEREBELLAR ARTERY AND
RIGHT ANTERIOR CEREBRAL TERRITORY INFARCT; NO HEMORRHAGIC
CONVERSION NOTED; NO NEW FOCUS OF INFARCT NOTED; INTERVAL
PROGRESSION OF HYDROCEPHALUS WITH SIGNS OF INCREASED PRESSURE
(SUBEPENDYMAL EFFUSION); BRAINSTEM REMAINS COMPRESSED;
SUPERIOR CEREBELLAR AND BASAL CISTERNS ARE STILL OBLITERATED;
UPWARD TRANSTENTORIAL HERNIATION AGAIN APPRECIATED; NO
SHIFTING OF MIDLINE STRUCTURES SEEN

NICU
CCU
CCU1 WTDG PRINSIPE, CAP-MR HCVD CAD ACS-STE KILLIP IV, CXR: REG OF INFIL RLL DEC FLUID RIGHT HTX NE 16 MG X 2 CC/JHR –
MARGARITO 67/M T2DM IN SR NYHAIIIC 3/2 NA 132 K 3.9 CREA 105 TAPERING
3/1 CHEST UTZ R 280 CC W/ ATELECTASIS

6
NA 135 K 4.2 CREA113 MG 2.19 FURO
WBC 14.2 HGB 149 APC 379 CREA 140 K 4.82 MG 0.19 SGPT 65.8 ENOX OD
ECG: SR WITH FREQ PVCS STE ELEV AVR, PRWP MEDS: ASA CLOP TWYNSTA
OFF ECHO EF 36% DILATED LV DIMENSIONS W/ SEVERE GLOBAL LANOX AMIO ROSU T,MZ
HYPOKINESIA TO AKINESIA W/ ONLY THE BASAL INFEROLATERAL LVFW ECTRIN CORLALAN
SHOWING SOME DEGREE OF CONTRACTILITY W/ GRADE II DIASTOLIC 2/27 LEVOFLOX
DYSFUNCTION NORMAL RVD W/ MILD HYPOCONTRACTILE WALLS 2/28 PIPTAZO
DILATED LA W/ LAVI OF 28.5ML/M2 NORMAL RA, MPA AND ARDS
THICKENED MVLS W/O ROM W/ MODERATE MR THICKENED AORTIC
CUSPS W/O ROM NO THROMBUS AND NO PE MILD PULMO HTN W/ SPAP
OF 41MMHG BY TR JET
CCU2 BSY BELLA MENDOZA ANEMIA ETIOLOGY TO BE SSS, VHD MVP S/P MVR S/P 2/28 TROP 0.04 ICA 1.13 MG 1.31 K 3.7 ALB 30 NA 140 WBC 4.9 HGB 95 FOR FOBT-AWAITING
87/F DETERMINED PPI DDD 2017 PLT 168 PROBNP 1371 CBC MG 3/2
DVT S/P IVC FILTER 2017 WBC 4.9 HGB 95 PLT 168 SEG 74 2/28 CEFUROXIME
S/P PPI INTEROOGATION 3/1
U/A PUS 6-10 RBC 2-4 EDEMANN 40MG ½ TAB OD
PRO BNP 1371
IVF PNSS 500CC X 10CC/HR
ECG NSSTWC
CXR CARDIOMEG MEDS: APPEBON, PRADAXA
SILYMARIN CARVED ALDAZIDE
LANOX OMEP ALLOP
CCU 3 HLC JERIELYN GRUTA 35/F HYPOVOLEMIC SHOCK 2 TO 3/2 ALB 22 K 3.1 DDIMER 3.3 FIBRINOGEN 268 HGB 83 PLT 57 WBC 9.L6 AC MODE FIO2 30%
ACUTE BLOOD LOSS 2 3/1 WBC 11.6 HGB 106 PLT 69 SEG 90 K3.0 CREA 117
UTERINE ATONY 2/27 HGB 24 WBC 8.8 SEG 76 APC 74 INR 1.39 ACT 55.4 APTT 28.9 30MEQS TO PRESENT IVF
S/P LSTCS 2 NON 2/26:WBC 11.1 HGB 43 SEG 60 PC 81 NA 140 K 3.5 CREA 84 BUN 3.5 PENDING 1PLT PHERESIS AND 2
REASSURING FHBPATTERN RPT PROTIME: 14.6 INR 1.3 ACT 51% U PRBC
APTT 47.6
S/P HYSTERECTOMY
PREOP CBC: HGB 144 WBC 9.0 PC 176 IVF: LEFT CUT DOWN:
S/P REMOVAL ARTERIAL LINE
STEROFUNDIN 50CC/HR
2/28 ECG: SINUS TACHYCARDIA
PROTIME > 120 SECS INR 5.0 ACT NOT DETECTED APTT > 180 LEFT FEM: PNSS 1L X 60CC

EF 80% TPEW STUDY DONE IN SINUS TACHYCARDIA ALB +FURO


SMALL LV CAVITY DIMENSIONS W/ NORMAL WALL THICKNESS OMEP TRANEX
W/ ADEQUATE WALL NOTION AND CONTRACTILITY W/ DERA 2/26 METRO
NORMAL RVD W/ NORMAL CONTRACTILITY NORMAL LA AND MEROP 2/28
RA NORMAL MPA AND ARDS THICKENED AMVL W/O ROM TRAMADOL
STRUCTURALLY NORMAL AV,TV AND PV W/ MILD AR, MILD TO
MODERATE TR AND PR NO THROMBUS AND NO PE
MILD PULMO HTN ( SPAP OF 37MMHG)
CCU 4 ADC FERNANDO DOLORES CAP HR HASCVD PROB CAD WBC 13.5 HGB 108 PLT 141 NA 137 K 5.5 REFER TO NEURO
71/F CKD SEC DM NEPHROPATHY CP ARREST PROB SEC TO ACS CKMB 118.7 ICA 1.20 MG 1.02 TROP 0.38 NA 137 K 5.5 HOLD HD
ECG ST 2/27 MEROPENEM
PANTOP CLOPI ATOR CLINDA
ECHO; EF 38% TPEW. STUDY DONE IN SINUS TACHYCARDIA CITICOLINE ENOX
CLVH W/ HK ENTIRE IVS, ANT AND ANTEROLATERAL LVFW B-A AND INF NORTHIX 16MG X 31 CC/HR-
AND INFEROLAT LVFW MID-BASE W/ DERA; N RVD WITH NC; N LA RA MPA TAPERING
AND ARDS; MILD MR, MAC; MILD TR; MILD PULMO HTN, NO T AND NO PE DOBU DC X 20 CC/HR
PITRESSIN X 10 CC/HR

CCU8 ELT VIRGINIA UY 70/F AGE S/P ARREST 3/2 (2 EPI) 3/1 ICA 1.14 MG 1.25 K 4.4 AC MODE 100%
624933 HCVD PROB CAD 2/28 WBC 14.9 HGB 101 PLT 220 CREA 67 ALB 22 NA 138 K 3.6 MG 1.68 CA
SEPSIS SEC PNEUMONIA IN PAROXYSMAL AF> SR NYHA 1.2 POSS TRACHEOSTOMY – NO
THE FC II PLEURAL FLUID CS LEFT: (-) CONSENT
IMMUNOCOMPROMISED PAROX SVT> SINUS TACH ½ 2/12 WBC 8.0 HGB 98 PLT 138 SEG 89
NA 141 K 3.5 CREA 71 DIET: NATURAL OF
PTB PAROX SVT > SR
CXR: PROGRESSION OF FLUID LEFT LUNG IVF: PLR 500CC X 30CC/HR
AGE PROB INFECTIOUS-
RESOLVED 2/5 MG 1.75 NA 143 ICA 14 AC MODE
BREAST CA S/P MRM 2013 2/3 CREA 57 WBC 8 HGB 107 PLT 224 K 3.8 NA 139
S/P CHEMO 12/8/17 1/24: UTX R 32CC, L 526CC DOPAMINE 200MG AT 13CC/HR-
T2DM 1/23 WBC 9.2 HGB 103 APC 184 SEG 92 NA 137 K 3.7 CREA 68 ICA 1.19 MG TAPERING
S/P CVA 1988 WITH R SIDED 2.41 NORTHIX X 16CC/HR
RESIDUAL 1`/21 NA 135 K3.3 ICA 1.25 MG 1.8
S/P THORA LEFT (1.1 L) 12/ 1/19: WBC 9.1 HGB 109 PLT 181 K 3.6 MG 0.77 MEDS:
PLEURAL FLUID TB CULTURE AND SENSITIVITY NO GROWTH AFTER 6 WKS 3/2 PIPTAZO
28
INCUBATION; ENOX
S/P THORA RIGHT 1.2 L ¼/17
PLEURAL FLUID AFB SMEAR: NO AFB SEEN MYRIN,
S/P PIGTAIL CATHETER TB PCR OF PLEURAL FLUID: POSITIVE DILTIAZEM, AMIO OD,
INSERTION, R (INITIAL DRAIN CXR: CWP FILM NOTED DECREASE IN FLUID ON THE RIGHT LUNG AS WELL TOLVAPTAN, MOSAPRIDE,
500CC) AS PNEUMONIC INFILTRATES ON BOTH LOWER LUNGS. STILL NOTED NOVOMIX, TAPDIN,
S/P CAHNGE OF PORTA CATH INFILTRATES ON LEFT UPPER LOBE NEUROBION, PANTOPRAZOLE,
1/19 1/14 HGB 102 CREA 72 PLT 145 K 4.7 ICA 1.2 MONTELUKAST, DILATAIR,
S/P REINTUBATION 2/1/18 UTZ: R 888CC/ L 467CC ALBIMIN + LASIX
S/P THORA LEFT 350CC CXR: INC INFIL BLL. NO CHANGE ON FLUID OF BOTH HEMITHORAX
DREAINES WITH 170CC CHEST CT SCAN: PROGRESSION OF PNA, MULTIPLE PULMO NODULES
LIKELY METS, LEFT THYROID GLAND ENLARGED W/ MULTIPLE SOLID
RESIDUAL 2/17
MASSESS
12/22EF EF 68% N LVD AND WT W. AWMC, MILD MR, MILD AR, MILD TR,
MOD PULMO HTN 69MMHG
10/23/17:EF: 73% N LVD AND WT W/ AWMC MOD PULMO HTN
CCU 7 DBY AUREA RIVERA 94/F ARF 2 CAP HR VT> AF RVR CXR: REG ODF PNA RIGHT HTX INSULIN DRIP
T2DM HCVD AC 50%
CKD 2 DM NEPHROPATHY LS AF, CHADSVASC 2 3/2 NA 134 K 3.3 CREA 270 NE 8MG AT 6CC
3/1 MG 1.8 K 3.4 CAL 1.22 DOPA 200MG AT 10CC
ECG: AF RVR LIDOCAINE 4GMS + 500CC AT
HGB 139 WBC 17.8 PC 224 BANDS 9 SEG 84 NA 139 K 3.5 TP 74 ALB 25 8CC/HR (1MG/KG)
SGPT 45 CREA 241 AMIO DRIP 600MG X 24HRS
VOLUVEN X 60 CC/HR

3/2 MEROPENEM/
3/2 LEVOFLOXACIN

PANTOP DRIP> PANTOP OD

CCU9 MCP NOLI MORENO 80M ARF TYPE 1SEC TO CAP-HR ASCVD PROBABLE CAD in ST 2D ECHO EF 57% NLVD HK BASAL ANT IVS AND INF AND INFEROLAT LVFW
T/C OBSTRUCTIVE FC IIB BM SIMV MODE 30%
PNEUMONIA VS ASPIRATION S/P CA (?) IVF: LEVOPHED DRIP 4MG X
PULMONARY MASS RIGHT 3/1 HGB 94 WBC 34.4 PLT 194 K 3 NA 149 CREA 170 6CC/HR-TAPERING
COPD SUSPECT ECG: STACH W/ PACS KLYTE
CXR: PNA 2/27 MEROPENEM
2/26 WBC 35.5 HGB 125 PLT 329 SEG 93 MEDS: TMZ AMBROXOL,
NA 135 K 3.0 CREA 160 MG 1.05 ICA 1.36 CORALAN 7.5MG BID, MYRIN P,
ATOR, DOXOPHYLLINE,
LACTULOSE, NAC, PANTO

PAV
J1 MCP KIM RYAN JOGUILON CVA BLEED R BG 38CC W/ ASCVD PROB CAD 3/1 NA 152 CREA 168
630715 30M SUBARACHNOID EXTENSION WBC 16.9 HGB 175 PLT 198 NA 138 K 4.6 CREA 130 NICARDIPINE X 10C C/HR

EF 57% CONC LVH WITH HYPOKINETIC ENTIRE IVS AND INFERIOR WALL MANNITOL KEPPRA IRBESARTAN
BASE TO APEX N RVD AND N CONTRACTILITY DILATED LA N RA MILD TR NO AMLO OMEP CLONIDINE
THROMBUS AND PERICARDIAL EFFUSION N PAP (22MMHG) NEVIBOLOL
L3 ELT RENATO DALIMO CPC UROTHELIAL CA ECG SR 2DED
631044 T2DM NA 136 K4.2 CREA 148 PENDING CLEARANCE
HGB 131 WBC 11 S62 PC 307 RADIAL CYSTECTOMY 3/3 12 PM
ATORVASTATIN TRAJENCTA
METRO CIPRO
L5 ADC DUMAYA JUAN 78M GASTRIC ADENOCARCINOMA 3/1 CBC HGB 121 WBC 10.6 PC 308 LABS NA 132 K 3.9 CREA 64 NPO
S/P BIOPSY LAST JANUARY ECG NSR KABIVEN X 36 HRS
2018 S/P ENDOSCOPY JAN CEFUROXIME
2018 LATEST CBC POST 3 UNITS TRANSFUSION
S/P GASTRIC SX 2/28 WBC 4.4 (5.6) HGB 97(47) PLATELET 277(310)
SEGMENTERS 72 LYMPHOCYTES 18

7
2DECHO 65% MILD MR/TR GRADE 1 LV DIASTOLIC DYSFUNCTION NORMAL
RVD WITH ADEQUAE WALL MOTION CONTRACTILITY
O5 ADC VIOLETA LUMBA 69F ASPIRATION PNEUMONIA HCVD WBC 20.2 HGB 106 PLT 308 NA 137 K 4.2 FOR MRI OF THE BRAIN
629641 CVA INFARCT R ECG ST W/ OCC PAC
DMT2 EF 59% N LVD AND WT W. AWMC W/ DERA MILD PULMO HTN TM 3 HRS ALT MV 1 HR
S/P TRACHE 2/26 ATOR PANTOP MUCINEX
CITICOLINE LOSRATN
METFORMIN LANTUS
2/21 CEFEPIME
FLUCONAZOLE
O10 WTDG VICTORIA DELA CRUZ CAPMR HCVD ADHF T/C DCMP NYHA WBC 11.7 HGB 103 PLT 285 NA 135 K 3 CREA 87 ALB 40 CKMB 21 TROP HOLD PLAVIX; DIUMIDE K
630731 75F DMT2 FC IIIC 0.02 COMPLETE BED REST
3/3 off EF 61% N LVD AND WT W/ AWMC W/ DERA, DILATED LA, MILD MR,
TR, N PAP PIPTAZO
KLYTE
FURO PANTOP RANEXA ATOR
CARVED GLICLA T,MZ
AMLODIPINE
HOLD NORPLAT S
P1 HLC NOLASCO DELOS UGIB 2 HCVD PROB CAD , SINUS 2/27: FBS 94.23 HBA1C 5.6 UA 273TPAG: 56/23/33/ 0.70 AWAITING
SANTOS 60/M CAP MR TACHYCARDIA, AFRVR >ST, 2/23 FT3 2.35 FT4 13.41 TSH 1.02 GENE EXPERT
SEPSIS 2 NYHA FC III
S/P EGD COLONOSCOPY CREA 77 K 3.8 DAT
3 GASTRIC ULCERS CLEAN IMDUR
BASE 2/24 CXR: NO SIGNIFICANT CHANGE IN CONSOLIDATION 2/25 MEROPENEM
S/P UTZ GUIDED THORA 2/27 AZITH
PE 450CC; 60CC RESIDUAL 2/22 ICA 1.01 (LOW) MG 1.34MG/DL K 3.3 OFFICIAL CBC HGB 71 (82) HCT FOR ENDOSCOPY-DEFER
0.21 (0.24) WBC 14.4 (15.1) SEG 69 LYMPHOS 18 PLT 319 (264)
ECG: ST WITH PVCS LOSARTAN, NELAPINE, CARVED,
CXR: PNEUMONIA WITH CONSOLIDATION R, CARDIOMEGALY TMZ, ROSU- HOLD
EF 77% NORMAL LVD W/ HYPERTROPHIED POSTERIOR WALLS W/
FLATTENIBG OF IVS DURING SYSTOLE AND DIASTOLE SUGGESTIVE OF RV
PRESSURE AND VOLUME OVERLOAD. THE REST OF LV SEGMENTS
CONTRACTS ADEQUATELY DILATED RVD W/ HYPOCONTRACTILE WALLS
DILATED LA AND RA NORMAL ARDS AND MPA THICKENED AORTIC CUSPS
W/O ROM W/ MILD AR. AAC THICKENED MVLS W/ O ROM W/ MILD MR.
MAC ST N TV AND PV W/ MODERATE TR AND PR NO THROMBUS AND NO
PE SEVERE PULMO HTN W/ SPAP OF 125MMHG BY TR JET METHOD
R1 ADC SAPELINO FLORES PTB CLINICALLY DIAGNOSED ECG NSR MGH
631014 37F HGB 121 WBC 7.5 S 78 PC 3O0 NA 139 K3.9
R6 LTAN AMBUBUYOG CAPHR HIE SEC TO PROLONGED CPR 2/25 WBC 12.5 HGB 71 PLT 356 CXR 3/3
630297 CARLTER 40F PNEUMOTHORAX L 2009 2/20 HGB 90 WBC 90 PLT 326 NA 117 K 5.1 CREA 38 TM1 LPM
S/P TRACH 2015 ECG ST
S/P UTZ GUIDED THORA L NAC KEPPRA RIVOTRIL
2/20 CHOLINERV USN
S/P CTT L 2/25 2/22 PIPTAZO
LANOXIN
S2 ADC ROSITA FRANCIA MDR TB S/P ARREST X 1 12/24 2/7 CXR: REGRESSION OF PNEUMONIC INFILTRATES B LUNGS MGH PCSO
CAT IV S/P CENTRAL LINE INSERTION 1/27 HGB 92 WBC 18.3 PC 197 S/P HD 3/2
CAP HR 12/24 CREA 393 1/8 CXR: INC HAZINESS L LLF
AKI s/p change to triple lumen 1/7 HGB 101 WBC 9.8PC 246 S/P BT 2 U PRBC 1/4
S/P REINTUBATION 1/3; 1/8 12/29 CREA 487
1/4 WBCV 14.2 HGB 91 PLT 256 SEG 65 MEDS: PIPTAZO 12/24
S/P HD 1/12 CXR: NO SIGNIFICANT CHANGE
S/P TRACHEOSTOMY 1/17 12/25: HGB 108 WBC 22.0 SEG 84 PC 184 NA 149 K 2.5 CREA 262 ICA 1.13
S/P R IJ CATH 2/13 MG 1.49
S/P IJ LEFT 3/2 12/24: K 1.7 ICA 1.01 NA 145 MG 0.5

CHARITY
FM FUENTES/ ZENAIDA CXR BIL PULMO CONGESTION 2DED
ANGHAD- HERNANDEZ 63/ F ECG LATERAL WALL ISCHEMIA FURO ISDN DOBUTAMINE
HCVD NCTEMI LATERAL
RAMOS/ TROP 10 CKMB 37 HGB 108 WBC 9 PC 308 CREA 104 LOSARTAN
BELISARIO/ WALL SR FC III
PALMEA
MM BELTRAN/M JAIME DELA ROSA INITIAL 2DED: EF 62% ECLVH HK APICAL TO MID SEPTUM, GR 1A , DILATED LA, DEFER CABG, AWAITING IDS
UKARA 70/M MILD MR, MILD TR CLEARANCE
CXR: PNA LLL
M/GUMPLA/ TROP I POSITIVENA 130 K 3.3 CREA 1 FOR CAROTID DVT ONCE ON
MARQUEZ CHARITY
ACS NSTE 3V CAD HOLD CLOPI 2/15/18
CAP MR S/P CA 2/12/18 NYHA FC II HOLD ASA 1DAY PRIOR TO SURGERY
HOLD CLEXANE 12HRS PRIOR
FOR CABG AT CHARITY
CLOPI-HOLD
ASA,CLOPID, ENOX, CEFTRI TRIMET
TAZO D2
AZITHRO D3
FM3 BELTRAN/M ONG IMELDA CXR: CARDIOMEG WITH BEG PULMO CONGESTION ECG: SR LAE PTWP MEDS: TELMI ATOR CLONIDINE
UKARA SALAMAT 49/F METABOLIC SYNDROME OSA NSSTWC WBC 9.8 HGB 185 APC165 NA 143 K 3.8 CREA 48 DIUMIDE K ASPIRIN
HCVD CAD ADHF IN SINUS
MORBIDLY OBESE TC EMPAGLIFLOZIN PANTOP
M/GUMPLA/ RHYTHM NYHA IIIC
POLYCYTHEMIA VERA T2DM SYMBICORT; CLEXANE
MARQUEZ
FM7 ELT/RAMOS/ MARICA SABLAD 19/F 2D ED: EF85% MVP W/ SEVERE MR. A2 SEGMENT OF AMVL PROLAPSE OR
SEVILLA/BELI FLAILS TOWARDS LA IN SYSTOLE. BOTH LEAFLETS ARE THICKENED W/ BLOOD CS
SARIO/PALM MOBILE ECHO DENSITY MEAS 1.7CMX1.2CM AT TNE ATRIAL SIDE OF POSS THOC TO PHC
EA AMPISUL
AMVL. THERE ARE LINEAR ECHOGENIC DENSITIES CONSISTENT W/ LOOSE
LEVOPHED TO 6CC TO TAPER UNTIL
OR TORN CHORDAL ELEMENTS ST N AV W/ TRIVIAL AR ST N TV W/ CONSUME
IE MODERATE TO SEVERE TR ST N PV W/ PR THE REST OF LV SEGMENTS
RHD MVP MR SEVERETR CONTRACTS ADEQUATELY DILATED LA AND RA DILATED RV W/ N
SEVERE FCII-III CONTRACTILITY MILD TO MODERATE PE SEVERE PULMO HTN W/ SPAP OF
78MMHG BT PEAK TR JET NO SHUNT ANOMALY
CBC HGB 84 WBC 22.4 S 83 PC 218 NA 131 K3.8 CREA 89
PROVISIONAL ECHO: EF 57% MOBILE ECHOGENIC DENSITY AT THE ATRIAL
SIDE OF THE MITRAL VALVE, MVP OF THE A2, FLATTENED IVS DURING
SYSTOLE, SEVERE MR, MOD TR,
FS4 BELTRAN/M DORETEO LOPEZ 76/F CKMB 19.3 TROP 0.01 KCL DRIP
UKARAM/GU COLON C/A AMIO DRIP
MPLA/MARQ T2DM HCVD ACUTE AF NYHA FC II
WBC 20.9 HGB 126 PLT 235 SEG 86 BANDS 8
UEZ S/P COLON SURGERY
NA 145 K 3.2 CREA 266 ICA 1.28 MG 0.84
FS 5 BELTRAN/M DORETIA LOPEZ 76/F 2/28 K 3.2 NA 145 TROP I 0.01 CKMB 13 AMIO TAB TID
UKARA
HCVD ACUTE AF IN RVR >>SR CREA 266 MG 2.04 ICA 1.28
M/GUMPLA/ COLON CA
CHA2DS2VASC 5 HASBLED 3
MARQUEZ S/P SIGMOIDECTOMY
NYHA FC II WBC 20.9 HGB 126 PLT 235 SEG 86

EF77% N LVD AWMC, DIL LA MILD MR, TR, AR, PR


FS 7 BELTRAN/M ROSALINDA DE VERA 2DED: EF 79%; AWMC
UKARA 51/F CPC- THYROID FOLLICULAR
NEOPLASM CXR: N
M/GUMPLA/
S/P THYROIDECTOMY
MARQUEZ
ECG: NSR; NSSTWC
MORTALITY
2502 WTDG FEDERICO UY 79/M ARF SEC TO CAP-HR HCVD WBC 22.1 HGB 92 PLT 307 SEG 95 MEDS: LANTUS, NAC,
631174 COMPLICATED UTI DOMPERIDONE, CLOPID, ATOR,
T2DM; R/O HHS NA 115 K 4.3 SGPT 1415 BUN 18 CREA 74 PANTO,
S/P CVA 3X ( 1986, 2009, 3/2 CLINDA; PIPTAZ
2015) TPAG: 52/17/35/0.49 INSULIN DRIP 100U X 6CC/HR

ECG: SINUS TACHY

CXR: CWPS: REGRESSION OF PNEUMONIC INFILTRATES RLL AND LML;


DEC AMOUNT OF FLUID IN CPS
ER

8
9